{"title":"自身免疫性疾病驱动生物学假阳性梅毒血清学:35,995项试验的回顾性队列","authors":"Bin Chen , ZiJian Jiang , MinHong Lyu","doi":"10.1016/j.cca.2025.120643","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To analyze the related factors that may cause the biological false-positive (BFP) reaction of syphilis screening test, with a particular focus on the correlation between autoimmune diseases and the biological false-positive results of syphilis screening test. This study aims to provide insights into the mechanisms underlying BFP reactions in autoimmune diseases and to improve the accuracy of syphilis serological diagnosis.</div></div><div><h3>Methods</h3><div>We conducted a retrospective review of 35,995 individuals who underwent syphilis screening at Guangzhou First People's Hospital from 2016 to 2023. The clinical characteristics including age, gender, and underlying diseases were compared between patients with BFP and those with a negative result of syphlilis screening test. The differences in autoantibody profiles and anticardiolipin antibody detection results of BFP patients and negative groups were analyzed.</div></div><div><h3>Results</h3><div>The observed incidence rate for biological false-positive reactions was 0.78 %, among which 96.7 % of cases exhibited relatively low titers (≤1:4). Significant differences in BFP responses were observed across different age groups (<em>P</em> < 0.05). In the false positive group, the positive rates of anti-double-stranded DNA antibody (ds-DNA), anti-ribosomal antibody (rRNP), soluble substance A (SSA), anti-Sm antibody (Sm), anti-ribonucleoprotein antibody (nRNP), histone, anti-nucleosome antibody (AauA), centromere antibody (CENP B), and antinuclear antibody (ANA) were significantly higher compared to the negative group (<em>P</em> < 0.05).</div></div><div><h3>Conclusion</h3><div>Autoimmune diseases and specific autoantibodies are key contributors to syphilis BFP reactions. Incorporating autoimmune testing may improve screening accuracy.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"579 ","pages":"Article 120643"},"PeriodicalIF":2.9000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Autoimmune diseases drive biological false-positive syphilis serology: A retrospective cohort of 35,995 tests\",\"authors\":\"Bin Chen , ZiJian Jiang , MinHong Lyu\",\"doi\":\"10.1016/j.cca.2025.120643\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>To analyze the related factors that may cause the biological false-positive (BFP) reaction of syphilis screening test, with a particular focus on the correlation between autoimmune diseases and the biological false-positive results of syphilis screening test. This study aims to provide insights into the mechanisms underlying BFP reactions in autoimmune diseases and to improve the accuracy of syphilis serological diagnosis.</div></div><div><h3>Methods</h3><div>We conducted a retrospective review of 35,995 individuals who underwent syphilis screening at Guangzhou First People's Hospital from 2016 to 2023. The clinical characteristics including age, gender, and underlying diseases were compared between patients with BFP and those with a negative result of syphlilis screening test. The differences in autoantibody profiles and anticardiolipin antibody detection results of BFP patients and negative groups were analyzed.</div></div><div><h3>Results</h3><div>The observed incidence rate for biological false-positive reactions was 0.78 %, among which 96.7 % of cases exhibited relatively low titers (≤1:4). Significant differences in BFP responses were observed across different age groups (<em>P</em> < 0.05). In the false positive group, the positive rates of anti-double-stranded DNA antibody (ds-DNA), anti-ribosomal antibody (rRNP), soluble substance A (SSA), anti-Sm antibody (Sm), anti-ribonucleoprotein antibody (nRNP), histone, anti-nucleosome antibody (AauA), centromere antibody (CENP B), and antinuclear antibody (ANA) were significantly higher compared to the negative group (<em>P</em> < 0.05).</div></div><div><h3>Conclusion</h3><div>Autoimmune diseases and specific autoantibodies are key contributors to syphilis BFP reactions. Incorporating autoimmune testing may improve screening accuracy.</div></div>\",\"PeriodicalId\":10205,\"journal\":{\"name\":\"Clinica Chimica Acta\",\"volume\":\"579 \",\"pages\":\"Article 120643\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica Chimica Acta\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0009898125005224\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898125005224","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
Autoimmune diseases drive biological false-positive syphilis serology: A retrospective cohort of 35,995 tests
Objectives
To analyze the related factors that may cause the biological false-positive (BFP) reaction of syphilis screening test, with a particular focus on the correlation between autoimmune diseases and the biological false-positive results of syphilis screening test. This study aims to provide insights into the mechanisms underlying BFP reactions in autoimmune diseases and to improve the accuracy of syphilis serological diagnosis.
Methods
We conducted a retrospective review of 35,995 individuals who underwent syphilis screening at Guangzhou First People's Hospital from 2016 to 2023. The clinical characteristics including age, gender, and underlying diseases were compared between patients with BFP and those with a negative result of syphlilis screening test. The differences in autoantibody profiles and anticardiolipin antibody detection results of BFP patients and negative groups were analyzed.
Results
The observed incidence rate for biological false-positive reactions was 0.78 %, among which 96.7 % of cases exhibited relatively low titers (≤1:4). Significant differences in BFP responses were observed across different age groups (P < 0.05). In the false positive group, the positive rates of anti-double-stranded DNA antibody (ds-DNA), anti-ribosomal antibody (rRNP), soluble substance A (SSA), anti-Sm antibody (Sm), anti-ribonucleoprotein antibody (nRNP), histone, anti-nucleosome antibody (AauA), centromere antibody (CENP B), and antinuclear antibody (ANA) were significantly higher compared to the negative group (P < 0.05).
Conclusion
Autoimmune diseases and specific autoantibodies are key contributors to syphilis BFP reactions. Incorporating autoimmune testing may improve screening accuracy.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.